ARMEN GARO H purchased $151 of PTIX
ARMEN GARO H (EXEC. CHAIR & PRINCIPAL OFF) purchased 685 shares of Protagenic Therapeutics, Inc.\new (PTIX) at $0.22 on 2026-08-06.
How this was made
The 30-second read
Why it matters
An insider open-market purchase is disclosed, but the transaction value is small and the filing contains no additional operational or financial updates.
Market read
Traders may note the insider buy, but the disclosed size and lack of accompanying catalysts make it a low-conviction signal.
What to watch
No context is provided on prior insider activity, total insider ownership changes beyond the post-transaction figure, or any concurrent company-specific catalysts.
Background
The article is a SEC Form 4 insider transaction disclosure for Protagenic Therapeutics, Inc.
Ticker impact
Protagenic Therapeutics disclosed an insider open-market purchase by its Executive Chair and Principal Officer: 685 shares at $0.2200 on 2026-08-06.
Low likelihood of a sustained price move based solely on this filing.
The filing is a disclosed insider transaction, but the disclosed size ($150.70) is small and there is no 10b5-1 plan or other accompanying corporate catalyst in the text.
Market effects
No clear sector read-through from a small insider buy in a single issuer.
None indicated.
None indicated.
Counterpoint
The buy may reflect personal liquidity planning or routine compensation-related activity rather than a strong forward-looking view.
Key entities
- issuerProtagenic Therapeutics, Inc.
Company subject of the Form 4 insider transaction disclosure (PTIX).
- insiderARMEN GARO H
Executive Chair and Principal Officer who purchased 685 shares at $0.2200 on 2026-08-06.